Kaskela Law LLC Investigates Fairness Of Proposed $59.00 Per Share Buyout Of Heidrick & Struggles International, Inc. (NASDAQ: HSII) Stockholders And Encourages Investors To Contact The Firm
October 6, 2025, Heidrick announced that it had agreed to be acquired by a consortium of private equity funds at a price of $59.00 per share in cash. Following the closing of the proposed transaction, Heidrick shareholders will be cashed out of their investment position and will not be able to share in any future post-closing financial upside.
The investigation so far has discovered that the proposed transaction appears to have significant conflicts of interest, thus making the sales process and amount of monetary consideration potentially unfair to the Company's current shareholders.
Heidrick shareholders who believe the buyout price is too law are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 to discuss their legal rights and options with respect to this transaction. Alternatively, investors may contact the firm by clicking on the following link (or by copying and pasting the link into your browser):
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. Since 2020, Kaskela Law LLC has helped to recover over $500 million for investors. For additional information about Kaskela Law LLC please visit .
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(... )
Adrienne Bell, Esq.
(... )
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
This notice may constitute attorney advertising in certain jurisdictions.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment